CEOs from Medtronic, Intuitive Surgical, Boston Scientific and Dexcom were on hand this week in San Francisco to discuss the year ahead at the J.P. Morgan Healthcare Conference.
The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline, company officials say.
BD invested $10 million last year to increase manufacturing capacity. The recent expansion has created more than 200 jobs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback